share_log

基石藥業-B:自願公告

CSTONE PHARMA-B: VOLUNTARY ANNOUNCEMENT

香港交易所 ·  Mar 3 23:27
Summary by Moomoo AI
基石藥業-B(「本公司」)於2024年3月4日宣布,根據2024年2月16日的公開信息,公司已不再是恆生綜合指數的合資格證券,並從2024年3月4日起不被納入港股通。本公司經合理查詢後確認,除了上述變動外,沒有知悉任何其他變動原因或需披露的內幕消息。公司強調,業務運營和財務狀況維持正常,並無重大變動,業務基本上按計劃進行。基石藥業將於三月底發布年度業績公告,並計劃在公告後舉行投資者介紹會,屆時將提供更多有關業務營運和財務狀況的資訊。
基石藥業-B(「本公司」)於2024年3月4日宣布,根據2024年2月16日的公開信息,公司已不再是恆生綜合指數的合資格證券,並從2024年3月4日起不被納入港股通。本公司經合理查詢後確認,除了上述變動外,沒有知悉任何其他變動原因或需披露的內幕消息。公司強調,業務運營和財務狀況維持正常,並無重大變動,業務基本上按計劃進行。基石藥業將於三月底發布年度業績公告,並計劃在公告後舉行投資者介紹會,屆時將提供更多有關業務營運和財務狀況的資訊。
KEYSTONE PHARMACEUTICAL-B (THE “COMPANY”) ANNOUNCED ON 4 MARCH 2024 THAT, ACCORDING TO PUBLIC INFORMATION ON 16 FEBRUARY 2024, THE COMPANY IS NO LONGER A QUALIFYING SECURITY FOR THE HANG SENG COMPOSITE INDEX AND WILL NOT BE INCLUDED IN HONG KONG SHARES FROM 4 MARCH 2024. After reasonable enquiries, the Company confirms that it is not aware of any other reasons for the changes or inside information to be disclosed other than the above changes. The company emphasizes that business operations and finances remain normal, without significant changes, and the business is basically carried out as planned. Keystone Pharmaceuticals will release its annual results announcement at the end of March and plans to hold an investor briefing following the announcement, at which time further information will be provided on its business operations and financial condition.
KEYSTONE PHARMACEUTICAL-B (THE “COMPANY”) ANNOUNCED ON 4 MARCH 2024 THAT, ACCORDING TO PUBLIC INFORMATION ON 16 FEBRUARY 2024, THE COMPANY IS NO LONGER A QUALIFYING SECURITY FOR THE HANG SENG COMPOSITE INDEX AND WILL NOT BE INCLUDED IN HONG KONG SHARES FROM 4 MARCH 2024. After reasonable enquiries, the Company confirms that it is not aware of any other reasons for the changes or inside information to be disclosed other than the above changes. The company emphasizes that business operations and finances remain normal, without significant changes, and the business is basically carried out as planned. Keystone Pharmaceuticals will release its annual results announcement at the end of March and plans to hold an investor briefing following the announcement, at which time further information will be provided on its business operations and financial condition.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more